Send to

Choose Destination
JPEN J Parenter Enteral Nutr. 2011 Jul;35(4):449-58. doi: 10.1177/0148607110380684. Epub 2011 May 31.

An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient.

Author information

Department of Pediatric Surgery, University of Texas Medical School at Houston, Houston, Texas 77030, USA.


The purpose of this review is to present the currently published evidence regarding the use, efficacy, potential mechanisms of action, and results of published clinical trials regarding the use of a Lentinula edodes mushroom-derived extract (active hexose correlated compound) as complementary therapy in patients with cancer. The authors explore the current preclinical and clinical evidence as it relates to this topic and its potential use in the surgical oncology patient. There has been a growing interest in stimulation of the immune system in trauma, cancer, and surgical patients in general. Little, however, has been written about some-of the supplements in widely used in Japan and China, but relatively unheard of in the United States.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center